We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -1.37% | 18.00 | 17.50 | 18.50 | 18.50 | 18.00 | 18.25 | 336,970 | 12:53:13 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.34 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/6/2019 07:24 | This may be one RNS where we do shift north in anticipation - will our patience be rewarded? | ambience | |
24/6/2019 07:24 | Another no revenue deal....more manufacturing. Sp to follow usual trend, start blue end red | hamid1970 | |
24/6/2019 07:21 | So not Bulgaria or Armenia this time. Just the US, Mexico and Canada..... Not much revenue there surely😜 | nobbygnome | |
24/6/2019 07:18 | Well done OPTI, big big deal. Wonder if a few posters will go back to hiding under their bridges today :) | woodaldo | |
24/6/2019 07:16 | Excellent deal, Agropur are a huge company! | primal123 | |
24/6/2019 07:13 | riskybusiness1 25 Apr '17 - 07:53 - 22570 of 50897 0 6 0 Cue the idiots that say '£57m company with £288k revenues'...actually very good at this stage considering opti has only stuck slimbiome in go figure purely to advertise it. That £288k won't be from just go figure alone it will be from partners paying to sit at the table and use optis tech. Lpldl has signed a profit sharing manufacturing agreement with Sacco, one of the biggest supplier of probiotics in Europe..... it is not going to be launched like a go figure! ____________________ ____________________ SOH's righthand man was saying the same stuff 2 years ago as he is saying now, lol | neftanikstinks | |
24/6/2019 07:11 | Looks like very good news - share price will probably go down :( | ambience | |
23/6/2019 23:31 | Oh dear, another HUR troll spitting his dummy out because nobby had a different opinion. Some of you trolls need a safe space, like they have in some uni's now where people can hide from conflicting views. | slartybartfaster | |
23/6/2019 22:26 | I think you get the picture now Nobby | gary38 | |
23/6/2019 22:26 | I totally agree starting with trolls who attack the HUR board. | gary38 | |
23/6/2019 22:23 | Drifting slowly down to 60p support area as price continues to follow bear trend. | gary38 | |
23/6/2019 22:16 | As long as we get our SBTX divi shortly after the 2nd commercial whopper ill be very pleased. | slartybartfaster | |
23/6/2019 21:08 | Slarty it was my version is simplified to get across how value was created. Convertible loan & percentages just adds complexity to explain | riskybusiness1 | |
23/6/2019 21:08 | There can be no mistaking Cath stating Stuart will build a £500m company. | slartybartfaster | |
23/6/2019 20:59 | 'Many will have understood differently to you, soh said differently at meetings a couple of years ago, as was reported on here'The information is out there & has been gone over many a times. Best to clarify with the right people rather than listen to what people twist from a meeting & write on here. Probably why your information is virtually always misleading. SOH possibly the most open ceo I have come across apart from GBrandon over at SKIN. Any concerns they are happy to address to investors. It's the duck & diver CEO's that must be avoided. I remember one Opti meeting I went to where SOH was talking about having SBTX independently valued by pharma & the potential of growing SBTX into a £250m company if the correct steps/hurdles were overcome. That information was regurgitated on here as SOH saying SBTX would be worth £250m within the next year.... Small minority, like yourself, take questionable information with a small element of truth & present it in a very misleading way.Very easy to take snippets of information & twist it. Best to read RNS or contact those who are well placed to inform rather than spread false accusations bordering libel. I suppose to be fair to you, if you don't have an interest & are not well informed yourself it's easy to often get things wrong. | riskybusiness1 | |
23/6/2019 20:58 | Risky, i thought it was 250k plus 460k via a convertible loan. | slartybartfaster | |
23/6/2019 19:20 | Nobby. All well and good starting an exclusive thread. I was denied access to the lemming opti BB because Elrico wrongly accused me of being somebody else. Only way I was going to be allowed in was to admit to being the other person and promising to behave myself. Didn't happen. | nik7907 | |
23/6/2019 18:00 | I think most actual investors realise & understand that the intention is to grow SBTX as a division in value & then release some of that value back to shareholders through a dividend to Opti shareholders. SBTX was an astute acquisition made by Opti bod for £250k back in 2017, value now for Optibiotix around £10m..... Opti would not even have SBTX if it wasn't for the foresight & entrepreneurship from management. Highly likely once the first commercial agreement arrives over at SBTX, Opti will look to give back some of that value to shareholders as promised, whilst leaving a significant interest for shareholders to profit from further growth from SBTX as it builds. Very rational & astute from a business perspective. Simply speaking they realised a tangible value by separately listing. 52% pre ipo SBTX worth £250k 'hived' off to a 41.9% holding worth £4.5m post ipo within a year. That's called value creation. Anyone saying otherwise simply hasn't understood it. | riskybusiness1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions